📊 Score Breakdown
Offering Ability
100
Cash Runway
65
Float Risk
2
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
40%
💰 Capital Raise
53%
• Under 12 months cash (7mo)
• Active shelf registration ($498M, 524% of market cap)
🔄 Reverse Split
40%
• 50-day avg $1.32 approaching $1 threshold
• 7 months cash with weak price
📉 Score Deterioration
10%
• Score in HIGH risk zone (64/100)
💹 Market Data
Market Cap$94.95M
Shares Outstanding85.54M
Float71.51M
Cash$4.45M
Debt$4.92M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 8.9% shares (2025Q4 vs prior)
48 institutional holders · 10.87M shares
#1
Voss Capital, LP
4.24M shares
#2
BIOS Capital Management, LP
1.69M shares
#3
VANGUARD GROUP INC
1.17M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest424.3K
Days to Cover1.0
% of Float0.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
424B5
ATM
May 04, 2026
EFFECT
EFFECT
Apr 30, 2026
S-1
SHELF
Apr 28, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for RNTX
📊 RNTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 RNTX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.